¹û¶³Ó°Ôº

XClose

¹û¶³Ó°Ôº News

Home
Menu

Comment: Public health perspective on new weight loss medications

30 January 2024

Dr Oliver Mytton (¹û¶³Ó°Ôº Great Ormond Street Institute of Child Health) argues that while new weight-loss medications are an important development, they mustn’t divert attention from a public health approach that addresses the underlying causes of obesity.

Dr Oliver Mytton (¹û¶³Ó°Ôº Great Ormond Street Institute of Child Health)

In an article in , Dr Oliver Mytton (¹û¶³Ó°Ôº Great Ormond StreetÌýInstitute of Child Health) cautions against relying on weight-loss drugs to tackle the obesity crisis. He argues that a more holistic, lifestyle orientated public health approach would have a greater impact for people with overweight or class I obesity, who largely remain ineligible for weight loss medications.Ìý

Links Ìý

Ìý